Capitol TrackerRachlin Evan Lockwood (Director at Iambic Therapeutics, Inc.) just bought $11.50M of $IAM
Filed with the SEC on 2026-10-19 (Form 4).
- Insider: Rachlin Evan Lockwood
- Company: Iambic Therapeutics, Inc. ($IAM)
- Transaction: Purchase on 2026-10-16
- Shares: 718,750
- Price: $16.00
- Value: $11.50M
Note: Bought at the IPO price…
See every highlight for $IAM →
Capitol Tracker tracks congressional trades, insider filings, and institutional 13F holdings as they're disclosed. See what else is happening →
More from the SEC filings: insider buying clusters · planned insider sales · big stakes (13D) · CEO and CFO changes
Get filings like this in your inbox
A free email each weekday with the biggest insider buys and sells filed with the SEC. One-click unsubscribe.